To collect additional data on 300 and 400 mg doses of PROMETRIUM in women with secondary amenorrhea
Showing 1 - 25 of >10,000
Plasmodium Vivax Malaria Trial in Worldwide (Tafenoquine, Chloroquine, Artemether 20 mg-Lumefantrine 120 mg)
Not yet recruiting
- Plasmodium Vivax Malaria
- Tafenoquine
- +2 more
-
Siem Reap, Cambodia
- +5 more
Jan 7, 2022
Prostate Tumor Trial in Seoul (remimazolam, Propofol)
Not yet recruiting
- Prostate Tumor
-
Seoul, Korea, Republic ofYonsei University College of Medicine
Oct 19, 2023
Female Breast Cancer Trial in Germany
Recruiting
- Female Breast Cancer
-
Moenchengladbach, NRW, Germany
- +4 more
Mar 30, 2023
Cystic Fibrosis Lung, Respiratory Infections, Recurrent, Chronic, Pseudomonas Aeruginosa Trial in Australia, United States
Not yet recruiting
- Cystic Fibrosis Lung
- +2 more
- RSP-1502
- Tobramycin inhalation solution
-
Tucson, Arizona
- +14 more
Aug 24, 2023
Chronic Myeloid Leukemia (CML) Philadelphia Chromosome Positive Trial in Worldwide (Imatinib, Nilotinib, Bosutinib)
Recruiting
- Chronic Myeloid Leukemia (CML) Philadelphia Chromosome Positive
- Imatinib
- +4 more
-
Longmont, Colorado
- +128 more
Aug 1, 2022
Alcohol Use Disorder Trial in New Haven, Providence, Charleston (ANS-6637, Placebo oral tablet)
Terminated
- Alcohol Use Disorder
- ANS-6637
- Placebo oral tablet
-
New Haven, Connecticut
- +2 more
Mar 9, 2022
Imfinzi/Imjudo uHCC Japan PMS _ Japan Post-Marketing
Not yet recruiting
- Unresectable Hepatocellular Carcinoma
- (no location specified)
Dec 19, 2022
Anxiety Trial in Rawalpindi (Cognitive Behavioral Therapy (CBT) for anxiety during pregnancy)
Completed
- Anxiety
- Cognitive Behavioral Therapy (CBT) for anxiety during pregnancy
-
Rawalpindi, PakistanHoly Family Hospital
Oct 18, 2022
Papilloma, Cervix Lesion Trial in Roma (Epigallocatechin gallate, Folic acid, Vitamin B12, and Hyaluronic Acid)
Completed
- Papilloma
- Cervix Lesion
- Epigallocatechin gallate, Folic acid, Vitamin B12, and Hyaluronic Acid
-
Roma, ItalyClinica Alma Res
Dec 21, 2022
Healthy Mums, Healthy Babies: Multiple Micronutrient
Not yet recruiting
- Birth Weight
- Multiple micronutrient supplementation (MMS)
- Iron folate supplementation (IFA)
-
Addis Ababa, EthiopiaEthiopia Public Health Institute
Jan 23, 2023
Pre-Exposure Prophylaxis, HIV, Telemedicine Trial in Scotts Valley (PrEPTECH website, Online PrEP resource list)
Recruiting
- Pre-Exposure Prophylaxis
- +2 more
- PrEPTECH website
- Online PrEP resource list
-
Scotts Valley, CaliforniaETR
Feb 18, 2022
Low Back Pain, Mechanical, Ibuprofen, Analgesia Trial in Ankara (Ibuprofen 400 mg, Ibuprofen 800 mg)
Completed
- Low Back Pain, Mechanical
- +3 more
- Ibuprofen 400 mg
- Ibuprofen 800 mg
-
Ankara, TurkeyAnkara City Hospital
Sep 26, 2023
Diabetic Neuropathies, Diabetes, Dietary Supplement Trial in Thessaloníki (Epineuron, Placebo group)
Completed
- Diabetic Neuropathies
- +2 more
- Epineuron
- Placebo group
-
Thessaloníki, Thessaloniki, GreeceUniversity General Hospital AHEPA
Aug 8, 2023
Musculoskeletal Pain Trial in Bronx (oxycodone/APAP, hydrocodone/APAP, codeine/APAP)
Completed
- Musculoskeletal Pain
- oxycodone/APAP
- +4 more
-
Bronx, New YorkMontefiore Medical Center
Jan 2, 2022
BCLC A Hepatocellular Carcinoma Non-resectable and Not Amenable for RFA Trial in Bobigny (Durvalumab/Tremelimumab in neoadjuvant
Not yet recruiting
- BCLC A Hepatocellular Carcinoma Non-resectable and Not Amenable for RFA
- Durvalumab/Tremelimumab in neoadjuvant and Durvalumab in adjuvant setting
-
Bobigny, FranceHospitl Avicenne
Sep 13, 2023
Healthy Subjects Trial in Shanghai (VV116 25mg Group, VV116 200mg Group, VV116 400mg Group)
Completed
- Healthy Subjects
- VV116 25mg Group
- +4 more
-
Shanghai, Shanghai, ChinaShanghai Xuhui Central Hospital
May 31, 2022
Clostridioides Difficile Infection Trial in Canada, United States (CRS3123, Active Comparator)
Recruiting
- Clostridioides Difficile Infection
- CRS3123
- Active Comparator
-
Fullerton, California
- +24 more
Jun 28, 2022
Mobile Advanced Multi-Parameter Reporting in Patients
Withdrawn
- Heart Attack
- +5 more
- ZOLL Arrhythmia Management System
- (no location specified)
Jul 13, 2023
Healthy Subjects, Opioid Antagonist, Pharmacokinetics Trial in West Bend (Four naloxone nasal spray doses (1 every 2.5 min),
Completed
- Healthy Subjects
- +2 more
- Four naloxone nasal spray doses (1 every 2.5 min)
- +2 more
-
West Bend, WisconsinSpaulding Clinical Research
Mar 17, 2022